Cart
sales@molnova.com
Chrysin 7-O-beta-gentiobioside
CAS No. 88640-89-5
Chrysin 7-O-beta-gentiobioside( Chrysin 7-O-β-gentiobioside )
Catalog No. M28253 CAS No. 88640-89-5
Chrysin 7-O-beta-gentiobioside, a glycosylation product of Chrysin, is from Spartium junceum.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 205 | Get Quote |
|
| 10MG | 329 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameChrysin 7-O-beta-gentiobioside
-
NoteResearch use only, not for human use.
-
Brief DescriptionChrysin 7-O-beta-gentiobioside, a glycosylation product of Chrysin, is from Spartium junceum.
-
DescriptionChrysin 7-O-beta-gentiobioside, a glycosylation product of Chrysin, is from Spartium junceum.
-
In Vitro——
-
In Vivo——
-
SynonymsChrysin 7-O-β-gentiobioside
-
PathwayOthers
-
TargetOther Targets
-
RecptorCOX
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number88640-89-5
-
Formula Weight578.52
-
Molecular FormulaC27H30O14
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC[C@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4c(c3)oc(cc4=O)-c3ccccc3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Obach RS, et al. In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam. Chem Res Toxicol. 2008 Sep;21(9):1890-9.
molnova catalog
related products
-
Bimagrumab
Bimagrumab (BYM338) is a human monoclonal antibody that binds to the activin type II receptor. Bimagrumab can be used to study diabetes and obesity.
-
BAY 2402234
BAY 2402234 (BAY2402234) is a novel potent, selective, orally bioavailable DHODH inhibitor with IC50 of 1.2 nM.
-
Mogroside III-A2
Mogroside III-A2 exhibits inhibitory effects with IC50 values of 346-400 mol ratio/32 pmol TPA. and shows weak inhibitory effects on activation of (+/-)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor.
